A Fortune 1000 of pharmaceutical products, the Company develops, manufactures and commercializes therapies for a variety of diseases and underserved conditions. With its Global Innovation and R&D Center in North America, the Company maintains advanced manufacturing operations across multiple facilities and its products are available in more than 100 countries. The company has over 15,000 employees worldwide.
After assessing a number of competing solutions, the company decided to choose Fidelis Cybersecurity’s intelligent deception platform, Fidelis Deception™. The platform came out on top as it was able to demonstrate both accurate detection of malware – some of which went undetected by other solutions – as well as clear and easy-tounderstand visibility of the Company’s numerous communication channels.
“With Fidelis Deception™, we’re changing the rules of the game. Now we have the attackers running for cover because they understand that we can find them even if they managed to bypass our perimeter,” says the Company’s Head of IT Security.